An investigational T-cell therapy shows promise against six viral infections common after stem cell transplants

Cloud technology with futuristic hologram on smartwatch

Posoleucel, an investigational allogeneic off-the-shelf T-cell therapy that simultaneously targets six different viruses, demonstrated promising antiviral efficacy and safety in a phase II study of patients who had undergone stem cell transplantation to treat their cancer or other blood diseases, according to a publication in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Menopause-like symptoms may strike before the menopause transition

Previous article

Free symptom questionnaire may help indicate whether a child has autism

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations